# Enterprise Imaging Final Readiness (Phase 2E.9A)

**Phase:** 2E.9A — program closure readiness  
**Date:** 2026-06-01  
**Prerequisite:** Waves 1–4 production **STABILIZED** · [`enterprise-imaging-final-audit.md`](enterprise-imaging-final-audit.md) **PASS**

---

## 1. Readiness summary

| Criterion | Status |
|-----------|--------|
| **Enterprise Imaging Expansion** | **COMPLETE** |
| **Production catalog** | **213** active studies |
| **Net-new workbook delivery** | **170 / 170** |
| **All waves production-stabilized** | **YES** |
| **Gate W2 ready for closure** | **YES** |
| **Blockers for 2E.9B** | **NONE** |
| **SAFE / NOT SAFE** | **SAFE** |

---

## 2. Wave production status

| Wave | Rows | Production active | Stabilization audit | Production seed |
|------|-----:|------------------:|---------------------|-----------------|
| Haiti baseline | **43** active | **43** | N/A (MVP) | MVP catalog |
| **1** | **37** | **37** | 2E.5C **PASS** | Stabilized |
| **2** | **61** | **61** | 2E.6E **PASS** | Stabilized |
| **3** | **41** | **41** | 2E.7E **PASS** | Stabilized |
| **4** | **31** | **31** | 2E.8E **PASS** | Stabilized |
| **Total active** | **213** | **213** | — | — |

---

## 3. Gate W2 closure readiness

Per [`enterprise-imaging-gate-w2.md`](enterprise-imaging-gate-w2.md):

| Gate area | Production status | Ready to close? |
|-----------|-------------------|:---------------:|
| W2-C-13 Master inventory **170** rows | Deployed | **YES** |
| W2-O-05 Staging seed per wave | Done (W1–W4) | **YES** |
| W2-O-06 Classifier backfill on new codes | Done at seed | **YES** |
| W2-O-08 Alias authoring | Done (~284+ wave-scoped aliases) | **YES** |
| W2-O-09 Preflight before production | Done per wave | **YES** |
| W2-O-11 US tuple pass | Applied (Wave 2) | **YES** |
| W2-O-12 `MRI_SPINE` B1B null regression | Verified production | **YES** |
| W2-O-01 Workbook CSV | Authoritative artifact | **YES** |
| W2-O-02 Per-wave clinical sign-off | Operational (Haiti pilot) | **2E.9B** formalize |
| W2-O-04 Pilot defer matrix | XR-3b / billing / retirement deferred | **Document in 2E.9B** |

| Verdict | |
|---------|---|
| **Gate W2 ready for closure** | **YES** — production delivery complete; 2E.9B records formal program closure |

---

## 4. Deferred items (not blocking closure)

| Item | Phase / gate | Notes |
|------|--------------|-------|
| **XR-3b** (+33 rows) | Optional parity | Not required for core **170** closure |
| **Gate W3 billing / CPT** | Billing | All net-new `PENDING_CPT_REVIEW`; **0** production CPT assigned |
| **Phase 2D retirement** | Separate | Design honored; execution not run |
| **Search phrase tuning** | Maintenance | 3 accepted English nuances documented |
| **Global duplicate alias groups (6)** | Baseline | Accepted; not introduced by expansion |

---

## 5. Validation evidence chain

| Phase | Evidence |
|-------|----------|
| 2E.8D | Production seed **31** + **72** aliases; postflight **22/22** |
| 2E.8E | Wave 4 **STABILIZED** · **SAFE** |
| 2E.9A | Enterprise audit **PASS** · **213** active · **170/170** |

---

## 6. Proceed to 2E.9B

**PHASE 2E.9B — Enterprise Imaging Program Closure** should:

1. Mark **Gate W2** **CLOSED** (with sign-off table).
2. Publish program completion summary for Haiti clinic operations.
3. Lock expansion scope: no further net-new rows without new gate.
4. Reference deferred tracks (XR-3b, W3 billing, 2D retirement) as explicit future gates.

---

## 7. Verdict

| Question | Answer |
|----------|--------|
| Enterprise Imaging Expansion complete? | **YES** |
| Active imaging | **213** |
| Net-new delivered | **170 / 170** |
| Gate W2 ready for closure? | **YES** |
| Proceed to 2E.9B? | **YES** |
| **SAFE / NOT SAFE** | **SAFE** |

---

*End of enterprise imaging final readiness (Phase 2E.9A).*
